Know Cancer

forgot password

Phase 2 Study of Circulating Tumor Cell in Non-Small Cell Lung Carcinoma

19 Years
Open (Enrolling)
Primary Lung Cancer

Thank you

Trial Information

Phase 2 Study of Circulating Tumor Cell in Non-Small Cell Lung Carcinoma

Inclusion Criteria:

- Suspected lung cancer

- Planned to undergo tissue biopsy. Tissue biopsy does not need to be limited to an
intrathoracic structures. Biopsies of the supraclavicular lymph nodes are allowed

- Age >18

Exclusion Criteria:

- Patients with history of a separate (not a primary lung cancer) malignancy within
past two years.

- Recent history (past two weeks) of trauma (INCLUDING diagnostic surgery, biopsy, etc)

- Prior lung cancer treatment chemotherapy, radiation, surgery, etc. in past two years.

- Inability to provide informed consent.

- Hgb less than 8.

Type of Study:


Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

CTC Enumeration

Outcome Description:

After informed consent of the patients, a single tube of blood will be drawn and processed according to the standard protocol. These blood draws will occur upon patient screening or rather the baseline of their treatment, a 6-12 week follow-up, as well as a 12 month follow-up.Furthermore, a biopsy will be taken between baseline and 6-12 week follow-up which will be used upon results of CTC enumeration to illustrate concordance. Epic Sciences staff is fully blinded to the clinical data of the patients until final analysis. Patients will be considered CTC positive at a count of greater than 2 CTCs per ml of blood.

Outcome Time Frame:

3 months from baseline, an average of 2 weeks post patient tissue biopsy

Safety Issue:


Principal Investigator

David Nelson, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Epic Sciences


United States: Institutional Review Board

Study ID:




Start Date:

November 2012

Completion Date:

Related Keywords:

  • Primary Lung Cancer
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Neoplastic Cells, Circulating



Billings Clinic Cancer Center Billings, Montana  59107-5100
Yale University New Haven, Connecticut  06520
Moores Cancer Center La Jolla, California  92093-0820